DIAGNOSIS AND CD5+ BETA CELLS IN PSYCHIATRIC PATIENTS

CD 5 + β-淋巴细胞亚群，这已与几个 自身免疫性疾病，据报道，增加了在一个子集， 精神分裂症患者 为了测试这一发现的特异性，我们 测量了CD 5 + β-淋巴细胞占总淋巴细胞的百分比， 来自81名社区精神卫生中心患者和10名 对照 根据诊断结果进行分析。CD5+ 药物滥用组的β细胞百分比显著高于药物滥用组， 与所有其他组相比，都有所上升。 占总人口的百分比 精神分裂症组高于对照组，但这种增加 没有统计学意义。

The CD5+ beta-lymphocyte subpopulation, which has been linked to several autoimmune diseases, has been reported to be increased in a subset of schizophrenic patients. To test the specificity of this finding, we measured the CD5+ beta-lymphocyte percentage of total lymphocytes in blood samples from 81 community mental health center patients and 10 controls. Results were analyzed according to diagnosis. The CD5+ beta-cell percentage in the substance abuser group was significantly elevated in comparison to all other groups. The percentage in the schizophrenic group was higher than the control group, but this increase was not statistically significant.